迪安诊断 - Financials

迪安诊断 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	12.2B	13.4B	20.3B	13.1B	10.6B
Revenue Growth %	-9.0%	-33.9%	55.0%	22.9%	--
Total Revenue	12.2B	13.4B	20.3B	13.1B	10.6B
Cost Of Revenue	8.8B	9.2B	12.7B	8.1B	6.6B
+Gross Profit	3.4B	4.2B	7.5B	5.0B	4.1B
Gross Margin %	28.0%	31.3%	37.2%	38.3%	38.2%
Total Operating Cost	12.3B	12.6B	17.5B	11.5B	9.4B
Selling Expenses	1.2B	1.4B	1.6B	1.2B	966.0M
Admin Expenses	859.0M	947.0M	1.3B	1.1B	766.0M
Rd Expenses	306.0M	433.0M	638.0M	425.0M	319.0M
Finance Expenses	198.0M	221.0M	298.0M	217.0M	196.0M
+Operating Income	-31.1M	842.0M	2.8B	1.8B	1.3B
Operating Margin %	-0.3%	6.3%	13.9%	14.0%	12.4%
Non Operating Income	11.3M	6.6M	2.3M	3.3M	13.2M
Non Operating Expenses	32.1M	50.5M	281.0M	50.2M	16.2M
Investment Income	38.7M	-17.6M	48.8M	55.3M	73.1M
Fair Value Change Income	-12.7M	-726,600	-56.2M	83.4M	-2.6M
Asset Disposal Income	-1.5M	-3.6M	-11.2M	6.4M	-79,300
Asset Impairment Loss	402.0M	16.7M	624.0M	272.0M	475.0M
Other Income	36.7M	98.9M	91.8M	65.1M	32.1M
Income Before Tax	-51.8M	798.0M	2.5B	1.8B	1.3B
Income Tax	117.0M	217.0M	681.0M	307.0M	247.0M
+Net Income	-169.0M	582.0M	1.9B	1.5B	1.1B
Net Margin %	-1.4%	4.3%	9.2%	11.3%	10.0%
Net Income Attributable	-357.0M	307.0M	1.4B	1.2B	803.0M
Minority Interest	188.0M	274.0M	428.0M	321.0M	267.0M
Eps Basic	-0.58	0.49	2.30	1.87	1.29
Eps Diluted	-0.58	0.49	2.30	1.86	1.29

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	1.8B	3.0B	4.2B	2.2B	1.7B
Trading Financial Assets	385.0M	418.0M	450.0M	427.0M	310.0M
Accounts Receivable	7.3B	8.1B	10.0B	6.3B	4.5B
Notes Receivable	166.0M	127.0M	109.0M	102.0M	72.6M
Notes And Accounts Receivable	7.4B	8.2B	10.1B	6.4B	4.6B
Prepayments	448.0M	400.0M	352.0M	339.0M	298.0M
Inventory	1.6B	1.5B	1.4B	1.3B	1.1B
Total Current Assets	11.9B	13.8B	16.8B	10.9B	8.2B
Long Term Equity Investment	960.0M	670.0M	1.1B	1.0B	1.3B
Fixed Assets	--	1.4B	1.2B	1.3B	1.1B
Fixed Assets Total	1.3B	1.4B	1.2B	1.3B	1.1B
Construction In Progress	--	7.9M	89.4M	12.9M	7.7M
Construction In Progress Total	10.0M	7.9M	89.4M	12.9M	7.7M
Intangible Assets	58.4M	59.0M	56.6M	48.6M	68.4M
Long Term Deferred Expenses	185.0M	238.0M	221.0M	157.0M	155.0M
Total Non Current Assets	3.9B	4.1B	4.3B	4.7B	4.2B
Total Assets	15.8B	17.9B	21.1B	15.6B	12.4B
Short Term Borrowings	616.0M	931.0M	1.9B	2.5B	2.4B
Accounts Payable	1.7B	1.8B	2.9B	1.9B	1.3B
Advance Receipts	--	--	--	--	--
Contract Liabilities	150.0M	154.0M	170.0M	205.0M	122.0M
Total Current Liabilities	4.7B	4.9B	7.7B	6.6B	5.6B
Long Term Borrowings	1.6B	2.3B	3.0B	888.0M	666.0M
Total Non Current Liabilities	2.3B	3.1B	3.8B	1.5B	765.0M
Total Liabilities	7.0B	8.0B	11.6B	8.1B	6.4B
Paid In Capital	625.0M	627.0M	627.0M	620.0M	620.0M
Capital Reserve	1.8B	1.9B	1.9B	1.7B	1.6B
Surplus Reserve	278.0M	256.0M	91.5M	78.7M	60.6M
Retained Earnings	4.0B	4.8B	4.8B	3.5B	2.4B
Minority Equity	2.2B	2.3B	2.1B	1.6B	1.3B
Equity Attributable	6.6B	7.6B	7.4B	5.8B	4.7B
Total Equity	8.8B	9.9B	9.5B	7.5B	6.0B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	13.5B	17.1B	17.6B	12.2B	10.4B
Tax Refunds Received	4.2M	731,700	6.9M	--	6.6M
Total Operating Cash Inflow	13.7B	17.4B	17.7B	12.4B	10.6B
Cash Paid For Goods	8.4B	10.2B	10.5B	7.3B	6.2B
Cash Paid To Employees	2.1B	2.6B	2.8B	1.8B	1.3B
Taxes Paid	571.0M	845.0M	1.0B	707.0M	459.0M
Total Operating Cash Outflow	12.5B	15.5B	16.1B	11.1B	9.0B
Operating Cash Flow	1.2B	1.9B	1.6B	1.3B	1.5B
Total Investing Cash Inflow	777.0M	1.1B	974.0M	484.0M	194.0M
Total Investing Cash Outflow	1.3B	1.8B	2.0B	1.0B	1.0B
Investing Cash Flow	-535.0M	-687.0M	-1.1B	-536.0M	-821.0M
Cash From Borrowings	1.9B	2.1B	6.0B	5.0B	4.0B
Dividends And Interest Paid	735.0M	460.0M	398.0M	354.0M	331.0M
Debt Repayments	2.4B	4.1B	4.4B	4.9B	3.9B
Total Financing Cash Inflow	2.2B	2.6B	6.7B	5.2B	4.3B
Total Financing Cash Outflow	4.0B	5.0B	5.2B	5.5B	4.5B
Financing Cash Flow	-1.8B	-2.4B	1.4B	-310.0M	-256.0M
Net Change In Cash	-1.2B	-1.2B	2.0B	468.0M	462.0M
Ending Cash Balance	1.8B	3.0B	4.1B	2.1B	1.7B
Capex	363.0M	702.0M	948.0M	589.0M	476.0M